Indian TALENT takes on European Challenge

Cordially

Invites you to an interactive session on

First ever Real World all comer Randomized Controlled Trial (TALENT) on an Indian Stent against globally accepted product from MNC giant Abbott.

The Session will be addressed by the following dignitaries:

·        Padma Shri Prof Upendra Kaul (MD, DM, FCSI, FSCAI, FAPSIC, FACC, FAMS),  Co-chairman of Talent RCT, Dean and ED Clinical Research and Academics - Fortis Health Care, ED Cardiology Fortis Flt. Lt., Editor in Chief: Asia Interventions, Chairman PRC, ICMR, Recipient of the prestigious Dr. B. C. Roy Award

·        Ganesh Sabat, CEO, SMT

·        Bhargav Kotadia, Vice Chairman, SMT

·        Dr Atul Abhyankar, Chief Medical Officer, SMT

The main pointers for PC:

• Importance and Relevance of Randomized Controlled Trial (RCT)
• Key Announcement from SMT
• Indian manufactured medical devices – A Boon
• Key Note by Padma Shri Prof Upendra Kaul (MD, DM, FCSI, FSCAI, FAPSIC, FACC, FAMS)

Details as below:

Date: 23^rd November, 2016

Venue:  Inspire Meeting Room, Le Méridien, Windsor Place · New Delhi, New Delhi, 110001

Timings: 11.00 am – 1pm

(To be followed by lunch)

Media RSVP:

Ankur Dutta +91 9711018758 ankur.dutta@madisonpr.in

Vishal Gaikwad 09769762190 vishal.gaikwad@madisonpr.in

Request you to kindly share you confirmation over the mail.

Looking forward to see you with us.